News Release Details
Entegris Reports Results for First Quarter of 2023
-
First-quarter revenue (as reported) of
$922.4 million , increased 42% from prior year - First-quarter revenue (proforma), decreased 3.7%
-
First-quarter GAAP diluted EPS of
$(0.59) -
First-quarter non-GAAP diluted EPS of
$0.65
Quarterly Financial Results Summary
(in thousands, except percentages and per share data)
GAAP Results |
|
|
|
Net sales |
|
|
|
Operating income |
|
|
|
Operating margin - as a % of net sales |
1.5% |
25.1% |
15.2% |
Net (loss) income |
( |
|
|
Diluted (loss) earnings per common share |
( |
|
|
Non-GAAP Results |
|||
Non-GAAP adjusted operating income |
|
|
|
Non-GAAP adjusted operating margin - as a % of net sales |
22.2% |
28.1% |
23.2% |
Non-GAAP net income |
|
|
|
Diluted non-GAAP earnings per common share |
|
|
|
Second-Quarter Outlook
For the second quarter ending
Segment Results
In connection with the completion of the CMC Materials acquisition, the Company now operates in four segments (which include the new APS division):
Specialty Chemicals and Engineered Materials (SCEM): SCEM provides advanced materials enabling complex chip designs and improved device electrical performance; including high-performance and high-purity process chemistries, gases and materials and safe and efficient delivery systems to support semiconductor and other advanced manufacturing processes.
Microcontamination Control (MC): MC offers advanced filtration solutions that improve customers’ yield, device reliability and cost; by filtering and purifying critical liquid chemistries and gases used in semiconductor manufacturing processes and other high-technology industries.
Advanced Materials Handling (AMH): AMH develops solutions that improve customers’ yields by protecting critical materials during manufacturing, transportation, and storage; including products that monitor, protect, transport and deliver critical liquid chemistries, wafers, and other substrates for a broad set of applications in the semiconductor, life sciences and other high-technology industries.
Advanced Planarization Solutions (APS): APS develops an end-to-end chemical mechanical planarization (CMP) solution and applications expertise delivered through advanced materials and high purity chemicals; including CMP slurries, pads, formulated cleans and other electronic chemicals used in the semiconductor manufacturing processes.
First-Quarter Results Conference Call Details
Entegris will hold a conference call to discuss its results for the first quarter on
Management’s slide presentation concerning the results for the first quarter will be posted on the Investor Relations section of www.entegris.com in the morning before the call.
About Entegris
Entegris is a leading supplier of advanced materials and process solutions for the semiconductor and other high-tech industries. Entegris has approximately 9,000 employees throughout its global operations and is ISO 9001 certified. It has manufacturing, customer service and/or research facilities in
Non-GAAP Information
The Company’s condensed consolidated financial statements are prepared in conformity with accounting principles generally accepted in
Cautionary Note on Forward Looking Statements
This news release contains forward looking statements. The words “believe,” “expect,” “anticipate,” “intend,” “estimate,” “forecast,” “project,” “should,” “may,” “will,” “would” or the negative thereof and similar expressions are intended to identify such forward looking statements. These forward looking statements may include statements about supply chain matters and inflationary pressures; future period guidance or projections; the Company’s performance relative to its markets, including the drivers of such performance; market and technology trends, including the duration and drivers of any growth trends; the development of new products and the success of their introductions; the focus of the Company’s engineering, research and development projects; the Company’s ability to execute on our business strategies, including with respect to Company’s expansion of its manufacturing presence in
|
|||
|
Three months ended |
||
|
|
|
|
Net sales |
|
|
|
Cost of sales |
520,711 |
339,826 |
541,545 |
Gross profit |
401,685 |
309,820 |
404,525 |
Selling, general and administrative expenses |
169,867 |
87,108 |
139,246 |
Engineering, research and development expenses |
71,906 |
46,715 |
68,041 |
Amortization of intangible assets |
57,574 |
12,651 |
53,462 |
|
88,872 |
— |
— |
Operating income |
13,466 |
163,346 |
143,776 |
Interest expense, net |
84,821 |
12,864 |
82,013 |
Other (income) expense, net |
(4,658) |
4,902 |
(3,447) |
(Loss) income before income tax expense |
(66,697) |
145,580 |
65,210 |
Income tax expense |
21,469 |
19,875 |
7,783 |
Net (loss) income |
|
|
|
|
|
|
|
|
|
|
|
Basic (loss) earnings per common share: |
|
|
|
Diluted (loss) earnings per common share: |
|
|
|
|
|
|
|
Weighted average shares outstanding: |
|
|
|
Basic |
149,426 |
135,670 |
149,039 |
Diluted |
149,426 |
136,552 |
149,909 |
|
||
|
|
|
ASSETS |
|
|
Current assets: |
|
|
Cash, cash equivalents and restricted cash |
|
|
Trade accounts and notes receivable, net |
511,435 |
535,485 |
Inventories, net |
830,939 |
812,815 |
Deferred tax charges and refundable income taxes |
38,845 |
47,618 |
Assets held-for-sale |
247,932 |
246,531 |
Other current assets |
118,864 |
129,297 |
Total current assets |
2,457,047 |
2,335,185 |
Property, plant and equipment, net |
1,464,420 |
1,393,337 |
Other assets: |
|
|
Right-of-use assets |
91,383 |
94,940 |
|
4,247,504 |
4,408,331 |
Intangible assets, net |
1,742,336 |
1,841,955 |
Deferred tax assets and other noncurrent tax assets |
29,795 |
28,867 |
Other |
34,602 |
36,242 |
Total assets |
|
|
LIABILITIES AND EQUITY |
|
|
Current liabilities |
|
|
Short-term debt, including current portion of long-term debt |
|
151,965 |
Accounts payable |
167,177 |
172,488 |
Accrued liabilities |
339,883 |
328,784 |
Liabilities held-for-sale |
11,617 |
10,637 |
Income tax payable |
103,901 |
98,057 |
Total current liabilities |
781,623 |
761,931 |
Long-term debt, excluding current maturities |
5,634,710 |
5,632,928 |
Long-term lease liability |
77,319 |
80,716 |
Other liabilities |
405,212 |
445,282 |
Shareholders’ equity |
3,168,223 |
3,218,000 |
Total liabilities and equity |
|
|
|
||
|
Three months ended |
|
|
|
|
Operating activities: |
|
|
Net (loss) income |
|
|
Adjustments to reconcile net (loss) income to net cash provided by operating activities: |
|
|
Depreciation |
46,775 |
23,905 |
Amortization |
57,574 |
12,651 |
Share-based compensation expense |
30,678 |
9,285 |
Loss on extinguishment of debt and modification |
2,787 |
— |
Impairment of |
88,872 |
— |
Loss from sale of business |
13,642 |
— |
Other |
(7,100) |
195 |
Changes in operating assets and liabilities, net of effects of acquisitions: |
|
|
Trade accounts and notes receivable |
8,379 |
(31,171) |
Inventories |
(34,852) |
(77,476) |
Accounts payable and accrued liabilities |
20,043 |
(22,323) |
Income taxes payable, refundable income taxes and noncurrent taxes payable |
15,867 |
16,760 |
Other |
(2,628) |
6,257 |
Net cash provided by operating activities |
151,871 |
63,788 |
Investing activities: |
|
|
Acquisition of property and equipment |
(133,992) |
(84,405) |
Proceeds from sale of business |
133,527 |
— |
Other |
108 |
1,123 |
Net cash used in investing activities |
(357) |
(83,282) |
Financing activities: |
|
|
Proceeds from revolving credit facility, short-term debt and long-term debt |
117,170 |
79,000 |
Payments of revolving credit facility, short-term debt and long-term debt |
(117,170) |
(79,000) |
Payments for dividends |
(15,170) |
(13,895) |
Issuance of common stock |
18,393 |
3,379 |
Taxes paid related to net share settlement of equity awards |
(9,406) |
(16,117) |
Other |
(299) |
(962) |
Net cash used in financing activities |
(6,482) |
(27,595) |
Effect of exchange rate changes on cash, cash equivalents and restricted cash |
561 |
(2,744) |
Increase (decrease) in cash, cash equivalents and restricted cash |
145,593 |
(49,833) |
Cash, cash equivalents and restricted cash at beginning of period |
563,439 |
402,565 |
Cash, cash equivalents and restricted cash at end of period |
|
|
|
|||
|
Three months ended |
||
Net sales |
|
|
|
Specialty Chemicals and Engineered Materials |
|
|
|
Advanced Planarization Solutions |
250,326 |
30,645 |
253,798 |
Microcontamination Control |
269,297 |
266,637 |
284,676 |
Advanced Materials Handling |
218,853 |
198,113 |
213,890 |
Inter-segment elimination |
(14,084) |
(11,525) |
(10,508) |
Total net sales |
|
|
|
|
Three months ended |
||
Segment profit |
|
|
|
Specialty Chemicals and Engineered Materials |
|
|
|
Advanced Planarization Solutions |
(32,790) |
11,159 |
56,661 |
Microcontamination Control |
95,997 |
98,618 |
107,413 |
Advanced Materials Handling |
48,165 |
46,690 |
48,045 |
Total segment profit |
114,640 |
194,159 |
226,947 |
Amortization of intangibles |
57,574 |
12,651 |
53,462 |
Unallocated expenses |
43,600 |
18,162 |
29,709 |
Total operating income |
|
|
|
|
|||
|
Three months ended |
||
|
|
|
|
|
|
|
|
Gross profit-GAAP |
|
|
|
Adjustments to gross profit: |
|
|
|
Restructuring costs 1 |
7,377 |
— |
— |
Adjusted gross profit |
|
|
|
|
|
|
|
Gross margin - as a % of net sales |
43.5% |
47.7% |
42.8% |
Adjusted gross margin - as a % of net sales |
44.3% |
47.7% |
42.8% |
1 Restructuring charges resulting from cost saving initiatives.
|
|||
|
Three months ended |
||
Adjusted segment profit |
|
|
|
SCEM segment profit |
|
|
|
Restructuring costs 1 |
6,523 |
— |
— |
Loss on sale of business 2 |
13,642 |
— |
— |
SCEM adjusted segment profit |
|
|
|
|
|
|
|
APS segment profit |
|
|
|
|
88,872 |
— |
— |
Restructuring costs 1 |
585 |
— |
— |
Gain on sale of business 2 |
— |
— |
(254) |
APS adjusted segment profit |
|
|
|
|
|
|
|
MC segment profit |
|
|
|
Restructuring costs 1 |
2,795 |
— |
— |
MC adjusted segment profit |
|
|
|
|
|
|
|
AMH segment profit |
|
|
|
Restructuring costs 1 |
1,254 |
— |
— |
AMH adjusted segment profit |
|
|
|
|
|
|
|
Unallocated general and administrative expenses |
|
|
|
Less: unallocated deal and integration costs |
19,975 |
6,254 |
22,369 |
Less: unallocated restructuring costs 1 |
86 |
— |
— |
Adjusted unallocated general and administrative expenses |
|
|
|
|
|
|
|
Total adjusted segment profit |
|
|
|
Less: adjusted unallocated general and administrative expenses |
23,539 |
11,908 |
7,340 |
Total adjusted operating income |
|
|
|
1 Restructuring charges resulting from cost saving initiatives.
2 Loss (gain) from the sale of businesses.
3 Non-cash impairment charges associated with goodwill.
|
|||
|
Three months ended |
||
|
|
|
|
Net sales |
|
|
|
Net (loss) income |
|
|
|
Net (loss) income - as a % of net sales |
(9.6%) |
19.3% |
6.1% |
Adjustments to net (loss) income: |
|
|
|
Income tax expense (benefit) |
21,469 |
19,875 |
7,783 |
Interest expense, net |
84,821 |
12,864 |
82,013 |
Other (income) expense, net |
(4,658) |
4,902 |
(3,447) |
GAAP - Operating income |
13,466 |
163,346 |
143,776 |
Operating margin - as a % of net sales |
1.5% |
25.1% |
15.2% |
Goodwill Impairment 1 |
88,872 |
— |
— |
Deal and transaction costs 2 |
3,001 |
5,008 |
258 |
Integration costs: |
|
|
— |
Professional fees 3 |
11,988 |
796 |
13,723 |
Severance costs 4 |
1,362 |
— |
2,273 |
Retention costs 5 |
1,280 |
— |
457 |
Other costs 6 |
2,345 |
450 |
2,105 |
Contractual and non-cash integration costs 7 |
— |
— |
3,553 |
Restructuring costs 8 |
11,242 |
— |
— |
Loss (gain) on sale of business 9 |
13,642 |
— |
(254) |
Amortization of intangible assets 10 |
57,574 |
12,651 |
53,462 |
Adjusted operating income |
204,772 |
182,251 |
219,353 |
Adjusted operating margin - as a % of net sales |
22.2% |
28.1% |
23.2% |
Depreciation |
46,775 |
23,905 |
41,882 |
Adjusted EBITDA |
251,547 |
206,156 |
261,235 |
Adjusted EBITDA - as a % of net sales |
27.3% |
31.7% |
27.6% |
1 Non-cash impairment charges associated with goodwill.
2 Deal and transaction costs associated the CMC acquisition and completed and announced divestitures.
3 Represents professional and vendor fees recorded in connection with services provided by consultants, accountants, lawyers and other vendors to assist us in integrating the recently acquired CMC into our operations. These fees arise outside of the ordinary course of our continuing operations.
4 Represent severance charges resulting from cost saving initiatives in connection with the CMC acquisition.
5 Represents retention charges related directly to the CMC acquisition and completed and announced divestitures, and are not part of our normal, recurring cash operating expenses.
6 Represents other employee related costs and other costs incurred relating to the CMC acquisition and the completed and announced divestitures. These costs arise outside of the ordinary course of our continuing operations.
7 Represents non-recurring costs associated with the CMC retention program that was agreed upon and set forth in the definitive acquisition agreement.
8 Restructuring charges resulting from cost saving initiatives.
9 Loss (gain) from the sale of businesses.
10Non-cash amortization expense associated with intangibles acquired in acquisitions.
|
|||
|
Three months ended |
||
|
|
|
|
GAAP net (loss) income |
|
|
|
Adjustments to net (loss) income: |
|
|
|
Goodwill Impairment 1 |
88,872 |
— |
— |
Deal and transaction costs 2 |
3,001 |
5,008 |
258 |
Integration costs: |
|
|
|
Professional fees 3 |
11,988 |
796 |
13,723 |
Severance costs 4 |
1,362 |
— |
2,273 |
Retention costs 5 |
1,280 |
— |
457 |
Other costs 6 |
2,345 |
450 |
2,105 |
Contractual and non-cash integration costs 7 |
— |
— |
3,553 |
Restructuring costs 8 |
11,242 |
— |
— |
Loss on extinguishment of debt and modification 9 |
3,880 |
— |
1,052 |
Loss (gain) on sale of business 10 |
13,642 |
— |
(254) |
|
(10,877) |
— |
— |
Interest expense, net 12 |
— |
4,683 |
— |
Amortization of intangible assets 13 |
57,574 |
12,651 |
53,462 |
Tax effect of adjustments to net (loss) income and discrete items14 |
1,639 |
(4,160) |
(9,605) |
Non-GAAP net income |
|
|
|
|
|
|
|
Diluted (loss) earnings per common share |
|
|
|
Effect of adjustments to net (loss) income |
|
|
|
Diluted non-GAAP earnings per common share |
|
|
|
|
|
|
|
Diluted weighted averages shares outstanding |
149,426 |
136,552 |
149,909 |
Effect of adjustment to diluted weighted average shares outstanding |
955 |
— |
— |
Diluted non-GAAP weighted average shares outstanding |
150,381 |
136,552 |
149,909 |
1 Non-cash impairment charges associated with goodwill.
2 Deal and transaction costs associated with the CMC acquisition and completed and announced divestitures.
3 Represents professional and vendor fees recorded in connection with services provided by consultants, accountants, lawyers and other vendors to assist us in integrating the recently acquired CMC into our operations. These fees arise outside of the ordinary course of our continuing operations.
4 Represent severance charges resulting from cost saving initiatives from the CMC acquisition.
5 Represents retention charges related directly to the CMC acquisition and completed and announced divestitures, and are not part of our normal, recurring cash operating expenses.
6 Represents other employee related costs and other costs incurred relating to the CMC acquisition and completed and announced divestitures. These costs arise outside of the ordinary course of our continuing operations.
7 Represents non-recurring costs associated with the CMC retention program that was agreed upon and set forth in the definitive acquisition agreement.
8 Restructuring charges resulting from cost saving initiatives.
9 Non-recurring loss on extinguishment of debt and modification of our Credit Amendment.
10 Loss (gain) from the sale of businesses.
11 Non-recurring gain from the termination fee with
12 Non-recurring interest costs related to the financing of the CMC acquisition.
13 Non-cash amortization expense associated with intangibles acquired in acquisitions.
14 The tax effect of pre-tax adjustments to net income was calculated using the applicable marginal tax rate during the respective years.
|
|
|
Second -Quarter Outlook |
Reconciliation GAAP Operating Margin to non-GAAP Operating Margin and Adjusted EBITDA Margin |
|
Net sales |
|
GAAP - Operating income |
|
Operating margin - as a % of net sales |
12% - 13% |
Deal, transaction and integration costs |
20 |
Amortization of intangible assets |
57 |
Adjusted operating income |
|
Adjusted operating margin - as a % of net sales |
21% - 22% |
Depreciation |
58 |
Adjusted EBITDA |
|
Adjusted EBITDA - as a % of net sales |
27% - 28% |
|
Second -Quarter Outlook |
Reconciliation GAAP net income to non-GAAP net income |
|
GAAP net income |
|
Adjustments to net income: |
|
Deal, transaction and integration costs |
20 |
Amortization of intangible assets |
57 |
Income tax effect |
(11) |
Non-GAAP net income |
|
|
Second -Quarter Outlook |
Reconciliation GAAP diluted earnings per share to non-GAAP diluted earnings per share |
|
Diluted earnings per common share |
|
Adjustments to diluted earnings per common share: |
|
Deal, transaction and integration costs |
0.13 |
Amortization of intangible assets |
0.38 |
Income tax effect |
(0.07) |
Diluted non-GAAP earnings per common share |
|
|
|
|
Three months ended |
|
|
Proforma Net Sales 1 |
|
Less: Wood treatment 2 |
(10,907) |
Proforma Net Sales - Non GAAP |
|
1 The above pro forma results include the addition of CMC Materials, Inc.’s financials recorded prior to the consummation of the merger with the Company on
2 The adjustment relates to removal of net sales related to CMC’s wood treatment business. Prior to the acquisition, CMC operated a wood treatment business, which manufactured and sold wood treatment preservatives for utility poles and crossarms. CMC exited this business during the first half of 2022, prior to our acquisition of CMC. The wood treatment business had no ongoing sales at the time of acquisition and removed for comparable purposes.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230511005204/en/
VP of Investor Relations
T + 1 952 556 1844
bill.seymour@entegris.com
Source: